prima is in the process of recruiting 800 patients for its phase 3 trial & at the moment have
-3 global production centres being organised -40+ qualified & trained cell collection centres worldwide to provide material for high quality production -up to 150 sites globally to complete patient recruitment
we are only 2 months away from phase 2b results being released, thats a hell of a lot of work being done if the results aren't positive !!!!!!!
plus in early october releasing the ics data results could give us a double boost
plus & this is pushing it , the nasdaq listing, expect increased interest & liquidity in the stock over time - especially behind clinical trial data that drives US analysts !!!!!!!!!!
PRR Price at posting:
9.8¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)